Posted by: Indonesian Children | May 9, 2010

Adverse Drug Reactions Among Children Over a 10-Year Period

Published online August 1, 2006
PEDIATRICS Vol. 118 No. 2 August 2006, pp. 555-562 (doi:10.1542/peds

ARTICLE

Adverse Drug Reactions Among Children Over a 10-Year Period

Jennifer Le, PharmDa, Thuy Nguyen, PharmDb, Anandi V. Law, PhDc, Jane Hodding, PharmDb  

a Departments of Pharmacy Practice
c Social and Administrative Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, California
b Department of Pharmacy Services, Miller Children’s Hospital, Long Beach, California

Abstract

OBJECTIVES. This study was designed to evaluate (1) the incidence and common types of adverse drug reactions among hospitalized children, (2) the frequency of adverse drug reaction reporting by health care providers, and (3) the follow-up processes resulting from adverse drug reactions. METHODS. A retrospective cohort study of pediatric patients who experienced an adverse drug reaction between January 1, 1995, and December 31, 2004, was conducted at a community-based, tertiary care, children’s teaching hospital. RESULTS. A total of 1087 adverse drug reactions were reported; the overall incidence was 1.6%. The severity of most adverse drug reactions was low (levels 1–3: 89%; high levels 4–6: 11%). Adverse drug reactions with low severity were significantly more common in both the general pediatric unit and the NICU. Adverse reactions resulting from use of antibiotics (particularly penicillins, cephalosporins, and vancomycin) were usually mild. In contrast, adverse drug reactions rated high in severity were significantly more common among reactions that led to hospital admission or occurred during surgery and among certain drug classes, including anticonvulsants and antineoplastic agents. Adverse drug reactions were reported by pharmacists (89%), nurses (10%), and physicians (<1%). Although documentation of physician notification occurred for 93% of adverse drug reactions, only 29% of cases were documented in the patient’s medical chart, 13% included follow-up education for individuals involved, and 10% were updated in the allergy profile of the hospital computer system. CONCLUSION. Measures to improve detection and reporting of adverse drug reactions by all health care professionals should be undertaken, to enhance our understanding of the nature and impact of these reactions in children.


Key Words: adverse drug reactions • childrenAbbreviations: ADR—adverse drug reaction 

1. World Health Organization. Lexicon of alcohol and drug terms published by the World Health Organization. Available at: www.who.int/substance_abuse/terminology/who_lexicon/en. Accessed July 25, 20052. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM. Timing of new black box warnings and withdrawals for prescription medications. JAMA. 2002;287 :2215 –2220[Abstract/Free Full Text]

3. Health Care Financing Administration. Medicare and Medicaid programs: hospital conditions of participation: provider agreements and supplier approval: HCFA: proposed rule. Fed Regist. 1997;62 :66726 –66763[Medline]

4. Gray J. Bill would force drug makers to give consumers data on risks. New York Times. July 25, 1996;A11

5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279 :1200 –1205[Abstract/Free Full Text]

6. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52 :77 –83[CrossRef][Web of Science][Medline]

7. Temple ME, Robinson RF, Miller JC, Hayes JR, Nahata MC. Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf. 2004;27 :819 –829[CrossRef][Web of Science][Medline]

8. Mitchell AA, Goldman P, Shapiro S, Slone D. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol. 1979;110 :196 –204[Abstract/Free Full Text]

9. McKenzie MW, Stewart RB, Weiss CF, Cluff LE. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm. 1973;30 :898 –903[Medline]

10. Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ. Reported adverse drug events in infants and children under 2 years of age. Pediatrics. 2002;110 (5). Available at: www.pediatrics.org/cgi/content/full/110/5/e53

11. Mitchell AA, Lacouture PG, Sheehan JE, Kauffman RE, Shapiro S. Adverse drug reactions in children leading to hospital admission. Pediatrics. 1988;82 :24 –29[Abstract/Free Full Text]

12. McKenzie MW, Marchall GL, Netzloff ML, Cluff LE. Adverse drug reactions leading to hospitalization in children. J Pediatr. 1976;89 :487 –490[CrossRef][Web of Science][Medline]

13. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277 :301 –306[Abstract/Free Full Text]

14. Gustafson SR, ed. The Pediatric Patient. Philadelphia, PA: JB Lippincott; 1971:112 –115

15. Salazar JC. Pediatric clinical trial experience: government, child, parent and physician’s perspective. Pediatr Infect Dis J. 2003;22 :1124 –1127[Web of Science][Medline]

16. McEvoy GK, Snow EK, Kester L, Litvak K, eds. AHFS Drug Information, 2005. Bethesda, MD: American Society of Health-System Pharmacists; 2005

17. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Health Syst Pharm. 1992;49 :2229 –2232[Medline]

18. Hartwig SC, Denger SD, Schneider PJ. Severity-indexed, incident report-based medication error-reporting program. Am J Health Syst Pharm. 1991;48 :2611 –2616[Abstract]

19. Rawlins MD. Clinical pharmacology: adverse reactions to drugs. BMJ. 1981;282 :974 –976[Free Full Text]

20. World Health Organization. International Drug Monitoring: The Role of the Hospital. Geneva, Switzerland: World Health Organization; 1966. Technical Report Series 425

21. Cullen DJ, Bates DW, Small SD, Cooper JB, Nemeskal AR, Leape LL. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv. 1995;21 :541 –548[Medline]

22. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc. 1998;5 :305 –314[Abstract/Free Full Text]

23. Etzel JV, Brocavich JM, Rousseau M. Impact of the development of a multidisciplinary adverse drug reaction committee. Hosp Pharm. 1995;30 :1083 –1087[Medline]

24. Clarkson A, Ingleby E, Choonara I, Bryan P, Arlett P. A novel scheme for the reporting of adverse drug reactions. Arch Dis Child. 2001;84 :337 –339[Abstract/Free Full Text]

25. Schlienger RG, Luscher TF, Schoenenberger RA, Haefeli WE. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;21 :110 –115[CrossRef][Web of Science][Medline]

26. Welsh CH, Pedot R, Anderson RJ. Use of morning report to enhance adverse event detection. J Gen Intern Med. 1996;11 :454 –460[Web of Science][Medline]

27. Sivaram CA, Johnson S, Tirmizi SN, Robertson V, Garcia D, Sorrells E. Morning report: a forum for reporting adverse drug reactions. Jt Comm J Qual Improv. 1996;22 :259 –263[Medline]

28. Weiss J, Krebs S, Hoffmann C, et al. Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection. Pediatrics. 2002;110 :254 –257[Abstract/Free Full Text]

29. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266 :2847 –2851[Abstract/Free Full Text]

30. Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother. 1994;28 :523 –527[Abstract]

31. Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA. 1998;280 :1317 –1320[Abstract/Free Full Text]

32. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients: Adverse Drug Events Prevention Study Group. JAMA. 1997;277 :307 –311[Abstract/Free Full Text]

33. Bessmertny O, Hatton RC, Gonzalez-Peralta RP. Antiepileptic hypersensitivity syndrome in children. Ann Pharmacother. 2001;35 :533 –538[Abstract]

34. Laugel V, Escande B, Entz-Werle N, et al. Severe acute pancreatitis in children receiving asparaginase: multicenter retrospective study. Arch Pediatr. 2005;12 :34 –41[CrossRef][Web of Science][Medline]

35. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285 :2114 –2120[Abstract/Free Full Text]

36. King WJ, Paice N, Rangrej J, Forestell GJ, Swartz R. The effect of computerized physician order entry on medication errors and adverse drug events in pediatric inpatients. Pediatrics. 2003;112 :506 –509[Abstract/Free Full Text]

37. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med. 2003;163 :1409 –1416[Abstract/Free Full Text]

38. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282 :267 –270[Abstract/Free Full Text]

39. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy. 2002;22 :134 –147[CrossRef][Web of Science][Medline]

Provided by

children’s ALLERGY CENTER online

JL TAMAN BENDUNGAN ASAHAN 5 JAKARTA PUSAT, JAKARTA INDONESIA 10210

PHONE : (021) 70081995 – 5703646

email :  judarwanto@gmail.com\ 

htpp://www.childrenallergyclinic.wordpress.com/ 

 

 

 

Information on this web site is provided for informational purposes only and is not a substitute for professional medical advice. You should not use the information on this web site for diagnosing or treating a medical or health condition. You should carefully read all product packaging. If you have or suspect you have a medical problem, promptly contact your professional healthcare provider. 

 

 

Copyright © 2010, Children Allergy Center Information Education Network. All rights reserved


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Categories

%d bloggers like this: